SA company to produce oral cholera vaccine as WHO warns of ‘unprecedented’ outbreaks
The production of raw materials is largely the missing step in the jab-manufacturing value chain across Africa
23 November 2022 - 21:14
SA's vaccine manufacturing capability has received another boost as local biopharmaceutical company Biovac becomes part of an international agreement to produce an oral cholera vaccine that will benefit mostly African countries...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
There’s never been a more important time to support independent media.
From World War 1 to present-day cosmopolitan South Africa and beyond, the Sunday Times has been a pillar in covering the stories that matter to you.
For just R80 you can become a premium member (digital access) and support a publication that has played an important political and social role in South Africa for over a century of Sundays. You can cancel anytime.
Already subscribed? Sign in below.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.